Biotech Chimerix Announces Successful Launch of ONC201 Phase 3 ACTION Study at Society for Neuro-Oncology Conference and Provides Operational Update December 8, 2022
Biotech ROSEN, GLOBALLY RECOGNIZED INVESTOR COUNSEL, Encourages Eiger BioPharmaceuticals, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – EIGR December 8, 2022
Biotech EIGER BIOPHARMACEUTICALS, INC. (EIGR) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Eiger BioPharmaceuticals, Inc. (EIGR) December 8, 2022
Biotech CNS Pharmaceuticals Announces Preliminary Results from Ongoing Potentially Pivotal Trial Evaluating Berubicin for the Treatment of Recurrent Glioblastoma Multiforme (GBM) December 8, 2022
Biotech Eiger BioPharmaceuticals Investors: Please contact the Portnoy Law Firm to recover your losses, January 9, 2023 deadline December 8, 2022
Biotech Eyenovia Announces Promotion of Bren Kern to Chief Operating Officer and Corporate Vice President December 8, 2022
Biotech Immutep Successfully Achieves Commercial Scale in Manufacturing of Eftilagimod Alpha December 8, 2022
Biotech Actinium Pharmaceuticals, Inc. Announces Research Collaboration with Columbia University to Study Actimab-A in AML Patients Following Transplant of Engineered Hematopoietic Stem Cells Gene Edited to be CD33 Negative December 8, 2022
Biotech Trevena Announces Poster Presentations of TRV045 Nonclinical Epilepsy Data, and OLINVYK Clinical Neurocognitive and GI Data, at Recent Medical Meetings December 8, 2022
Biotech SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SBCF, PFHD, EQ, MTCR December 8, 2022